Fos family protein degradation by the proteasome

Biochemical Society Transactions

Volumn 36, Issue 5, 2008, Pages 858-863

  Gomard, Tiphanie ^a   Jariel Encontre, Isabelle ^a   Basbous, Jihane ^a   Bossis, Guillaume ^a   Mocquet Torcy, Gabriel ^a   Piechaczyk, Marc ^a  

^a CNRS   (France)

Author keywords

Activator protein 1 (AP 1); c Fos; Fra 1; Proteasome; Protein degradation; Ubiquitin

Indexed keywords

MITOGEN ACTIVATED PROTEIN KINASE; PROTEASOME; PROTEIN C FOS; PROTEIN FOS; TRANSCRIPTION FACTOR FOSB; TRANSCRIPTION FACTOR FRA 1; TRANSCRIPTION FACTOR FRA 2;

APOPTOSIS; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL STRESS; CELLULAR DISTRIBUTION; CONFERENCE PAPER; GENE CONTROL; HUMAN; IMMUNE RESPONSE; IMMUNOMODULATION; NONHUMAN; OSTEOSARCOMA; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN DOMAIN; PROTEIN FUNCTION; PROTEIN HYDROLYSIS; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; PROTEIN STRUCTURE; SIGNAL TRANSDUCTION; SKIN TUMOR; UBIQUITINATION;

AMINO ACID SEQUENCE; ANIMALS; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; MICE; MITOGEN-ACTIVATED PROTEIN KINASES; MOLECULAR SEQUENCE DATA; PROTEASOME ENDOPEPTIDASE COMPLEX; PROTO-ONCOGENE PROTEINS C-FOS; SEQUENCE ALIGNMENT; UBIQUITIN;

EID: 53849104631     PISSN: 03005127     EISSN: None     Source Type: Journal    
DOI: 10.1042/BST0360858     Document Type: Conference Paper

References (53)

1. Chinenov, Y. and Kerppola, T.K. (2001) Close encounters of many kinds: Fos-Jun interactions that mediate transcription regulatory specificity. Oncogene 20, 2438-2452
2. Herdegen, T. and Waetzig, V. (2001) AP-1 proteins in the adult brain: facts and fiction about effectors of neuroprotection and neurodegeneration. Oncogene 20, 2424-2437
3. Hess, J., Angel, P. and Schorpp-Kistner, M. (2004) AP-1 subunits: quarrel and harmony among siblings. J. Cell Sci. 117, 5965-5973
4. Jochum, W., Passegue, E. and Wagner, E.F. (2001) AP-1 in mouse development and tumorigenesis. Oncogene 20, 2401-2412
5. Mechta-Grigoriou, F., Gerald, D. and Yaniv, M. (2001) The mammalian Jun proteins: redundancy and specificity. Oncogene 20, 2378-2389
6. Shaulian, E. and Karin, M. (2002) AP-1 as a regulator of cell life and death. Nat. Cell Biol. 4, E131-E136
7. Wagner, E.F. and Eferl, R. (200S) Fos/AP-1 proteins in bone and the immune system. Immunol. Rev. 208, 126-140
8. Milde-Langosch, K. (2005) The Fos family of transcription factors and their role in tumourigenesis. Eur. J. Cancer 41, 2449-2461
9. van Dam, H. and Castellazzi, M. (2001) Distinct roles of Jun:fos and Jun:ATF dinners in oncogenesis. Oncogene 20, 2453-2464
10. Young, M.R. and Colburn, N.H. (2006) Fra-1 a target for cancer prevention or intervention. Gene 379, 1-11
11. Eferl, R. and Wagner, E.F. (2003) AP-1: a double-edged sword in tumorigenesis. Nat. Rev. Cancer 3, 859-868
12. Piechaczyk, M. and Blanchard, J.M. (1994) c-fos; proto-oncogene regulation and function. Crit. Rev. Oncol. Hematol. 17, 93-131
13. 1 transition in mouse fibroblasts: in vitro and in vivo associations. Mal. Cell. Biol. 11, 2451-2459
14. 1 transition and during exponential growth in mouse fibroblasts: differential role of Fos proteins. Mol. Cell. Biol. 12, 5015-5023
15. Lallemand, D., Spyrou, G., Yaniv, M. and Pfarr, C.M. (1997) Variations in Jun and Fos protein expression and AP-1 activity in cycling, resting and stimulated fibroblasts. Oncogene 14, 819-830
16. Bergers, G., Graninger, P., Braselmann, S., Wrighton, C. and Busslinger, M. (1995) Transcriptional activation of the fro-1 gene by AP-1 is mediated by regulatory sequences in the first intron. Mol. Cell. Biol. 15, 3748-3758
17. Saez, E., Rutberg, S.E., Mueller, E., Oppenheirn, H., Smoluk, J., Yuspa, S.H. and Spiegelman, B.M. (1995) c-fos is required for malignant progression of skin tumors. Cell 82, 721-732
18. Fleischmann A., Jochum, W., Eferl, R., Witowsky, J. and Wagner, F.F. (2003) Rhabdomyosarcoma development in mice lacking Trp53 and Fos: tumor suppression by the Fos protooncogene. Cancer Cell 4, 477-482
19. Mikula, M., Gotzmann, J., Fischer, A.N., Wolschek, M.F., Thallinger, C., Schulte-Hermann, R., Beug, H. and Mikulits, W. (2003) The proto-oncoprotein c-Fos negatively regulates hepatocellular tumorigenesis. Oncogene 22, 6725-6738
20. Vial, E. and Marshall, C.J. (2003) Elevated ERK-MAP kinase activity protects the FOS family member FRA-1 against proteasomal degradation in colon carcinoma cells. J. Cell Sci. 116, 4957-4963
21. Belguise, K., Kersual, N., Galtier, F. and Chalbos, D. (2005) FRA-1 expression level regulates proliferation and invasiveness of breast cancer cells. Oncogene 24, 1434-1444
22. Casalino, L., Bakiri, L., Talotta, F., Weitzman, J.B., Fusco, A., Yaniv, M. and Verde, P. (2007) Fra-1 promotes growth and survival in RAS-transformed thyroid cells by controlling cyclin A transcription. EMBO J. 26, 1878-1890
23. Murphy, L.O. and Blenis, J. (2006) MAPK signal specificity: the right place at the right time. Trends Biochem. Sci. 31, 268-275
24. Terasawa, K., Okazaki, K. and Nishida, E. (2003) Regulation of c-Fos and Fra-1 by the MEK5-ERK5 pathway. Genes Cells 8, 263-273
25. Gruda, M.C., Kovary, K., Metz, R. and Bravo, R. (1994) Regulation of Fra-1 and Fra-2 phosphorylation differs during the cell cycle of fibroblasts and phosphorylation in vitro by MAP kinase affects DNA binding activity. Oncogene 9, 2537-2547
26. Chen, R.H., Abate, C. and Blenis, J. (1993) Phosphorylation of the c-Fos transrepression domain by mitogen-activated protein kinase and 90-kDa ribosomal 56 kinase. Proc. Natl. Acad. Sci. U.S.A. 90, 10952-10956
27. Chen, R.H., Juo, P.C., Curran, T. and Blenis, J. (1996) Phosphorylation of c-Fos at the C-terminus enhances its transforming activity. Oncogene 12, 1493-1502
28. rsk2. J. Biol. Chem. 274, 3385-3395
29. Okazaki, K. and Sagata, N. (1995) The Mos/MAP kinase pathway stabilizes c-Fos by phosphorylation and augments its transforming activity in NIH 3T3 cells. EMBO J. 14, 5048-5059
30. Monje, P., Marinissen, M.J. and Gutkind, J.S. (2003) Phosphorylation of the carboxyl-terminal transactivation domain of c-Fos by extracellular signal-regulated kinase mediates the transcriptional activation of AP-1 and cellular transformation induced by platelet-derived growth factor. Mol. Cell. Biol. 23, 7030-7043
31. Monje, P., Hernandez-Losa, J., Lyons, R.J., Castellone, M.D. and Gutkind, J.S. (2005) Regulation of the transcriptional activity of c-Fos by ERK. A novel role for the prolyl isomerase PIN1. J. Biol. Chem. 280, 35081-35084
32. Murphy, L.O., Smith, S., Chen, R.H., Fingar, D.C. and Blenis, J. (2002) Molecular interpretation of ERK signal duration by immediate early gene products. Nat. Cell Biol. 4, 556-564
33. Ferrara, P., Andermarcher, E., Bossis, G., Acquaviva, C., Brockly, F., Jariel-Encontre, I. and Piechaczyk, M. (2003) The structural determinants responsible for c-Fos protein proteasomal degradation differ according to the conditions of expression. Oncogene 22, 1461-1474
34. 1 phase of the cell cycle is determined by the duration of mitogen-activated protein kinase activation. Mol. Cell. Biol. 19, 330-341
35. Mechta, F., Lallemand, D., Pfaff, C.M. and Yaniv, M. (1997) Transformation by ras modifies AP1 composition and activity. Oncogene 14, 837-847
36. Treinies, I., Paterson, H.F., Hooper, S., Wilson, R. and Marshall, C.J. (1999) Activated MEK stimulates expression of AP-1 components independently of phosphatidylinositol 3-kinase (P13-kinase) but requires a P13-kinase signal to stimulate DNA synthesis. Mol- Cell. Biol. 19, 321-329
37. Salvat, C., Jariel-Encontre, I., Acquaviva, C., Omura, S. and Piechaczyk, M. (1998) Differential directing of c-Fos and c-Jun proteins to the proteasome in serum-stimulated mouse embryo fibroblasts. Oncogene 17, 327-337
38. Bossis, G., Ferrara, P., Acquaviva, C., Jariel-Encontre, I,. and Piechaczyk, M. (2003) c-Fos proto-oncoprotein is degraded by the proteasome independently of its own ubiquitinylation in vivo. Mol. Cell- Biol. 23, 7425-7436
39. 0-to-S phase transition. Oncogene 20, 7563-7572
40. Farras, R., Bossis, G., Andermarcher, E., Jariel-Encontre, I. and Piechaczyk, M. (2005) Mechanisms of delivery of ubiquitylated proteins to the proteasome: new target for anti-cancer therapy? Crit. Rev. Oncol. Hematol. 54, 31-51
41. Sasaki, T., Kojima, H., Kishimoto, R., Ikeda, A., Kunimoto, H. and Nakajima, K. (2006) Spatiotemporal regulation of c-Fos by ERK5 and the E3 ubiquitin ligase UBR1, and its biological role. Mal. Cell 24, 63-75
42. Roux, P., Blanchard, J.M., Fernandez, A., Lamb, N., Jeanteur, P. and Piechaczyk, M. (1990) Nuclear localization of c-Fos, but not v-Fos proteins, is controlled by extracellular signals. Cell 63, 341-351
43. Basbous, J., Chalbos, D., Hipskind, R., Jariel-Encontre, I. and Piechaczyk, M. (2007) Ubiquitin-independent proteasomal degradation of Fra-1 is antagonized by Erk1/2 pathway-mediated phosphorylation of a unique C-terminal destabilizer. Mol. Cell. Biol. 27, 3936-3950
44. Murphy, L.O., MacKeigan, J.P. and Blenis, J. (2004) A network of immediate early gene products propagates subtle differences in mitogen-activated protein kinase signal amplitude and duration. Mol. Cell. Biol. 24, 144-153
45. Casalino, L., De Cesare, D. and Verde, P. (2003) Accumulation of Fra-1 in Ras-transformed cells depends on both transcriptional autoregulation and MEK-dependent posttranslational stabilization. Mol. Cell. Biol. 23, 4401-4415
46. Campbell, K.M., Terrell, A.R., Laybourn, P.J. and Lumb, K.J. (2000) Intrinsic structural disorder of the C-terminal activation domain from the bZIP transcription factor Fos. Biochemistry 39, 2708-2713
47. Hoyt, M.A. and Coffino, P. (2004) Ubiquitin-free routes into the proteasome. Cell. Mol. Life Sci. 61, 1596-1600
48. Rechsteiner, M. and Hill, C.P. (2005) Mobilizing the proteolytic machine: cell biological roles of proteasome activators and inhibitors. Trends Cell Biol. 15, 27-33
49. Hoffmann, E., Thiefes, A., Buhrow, D., Dittrich-Breiholz, O., Schneider, H., Resch, K. and Kracht, M. (2005) MEK1-dependent delayed expression of Fos-related antigen-1 counteracts c-Fos and p65 NF-κB-mediated interleukin-8 transcription in response to cytokines or growth factors. J. Biol. Chem. 280, 9706-9718
50. Haglund, K. and Dikic, I. (2005) Ubiquitylation and cell signaling. EMBO J. 24, 3353-3359
51. Schnell, J.D. and Hicke, L. (2003) Non-traditional functions of ubiquitin and ubiquitin-binding proteins. J. Biol. Chem. 278, 35857-35860
52. Young, M.R., Nair, R., Bucheimer, N., Tulsian, P., Brown, N., Chapp, C., Hsu, T.C. and Colburn, N.H. (2002) Transactivation of Fra-1 and consequent activation of AP-1 occur extracellular signal-regulated kinase dependently. Mol. Cell. Biol. 22, 587-598
53. Jariel-Encontre, I., Bossis, G. and Piechaczyk, M. (2008) Ubiquitin-independent degradation of proteins by the proteasome. Biochim. Biophys. Acta, doi:10-1016/j.bbcan.2008.05.004